These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3286880)

  • 1. The role of methotrexate in osteosarcoma.
    Grem JL; King SA; Wittes RE; Leyland-Jones B
    J Natl Cancer Inst; 1988 Jul; 80(9):626-55. PubMed ID: 3286880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for osteosarcoma without high-dose methotrexate: another piece in the puzzle.
    Blay JY
    Onkologie; 2007 May; 30(5):226-7. PubMed ID: 17460415
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
    Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
    Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
    Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
    Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
    Saeter G; Alvegård TA; Elomaa I; Stenwig AE; Holmström T; Solheim OP
    J Clin Oncol; 1991 Oct; 9(10):1766-75. PubMed ID: 1717666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma.
    Weiner MA; Harris MB; Lewis M; Jones R; Sherry H; Feurer EJ; Johnson J; Lahman E
    Cancer Treat Rep; 1986 Dec; 70(12):1431-2. PubMed ID: 3466693
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose methotrexate in osteosarcoma--Mayo Clinic studies.
    Edmonson JH
    NCI Monogr; 1987; (5):67-9. PubMed ID: 3481039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcoma.
    Leavey PJ; Mantadakis E; Maale G
    Pediatr Hematol Oncol; 2002; 19(7):483-9. PubMed ID: 12217194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose methotrexate (HD-MTX) used as an adjunct with other chemotherapeutics for the treatment of osteosarcoma.
    Liu Y; Xu Y; Lin N; Jiang S; Wang Y; Ye Z
    Cell Biochem Biophys; 2015 Mar; 71(2):1097-104. PubMed ID: 25417058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
    Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
    Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature.
    Delepine N; Delepine G; Bacci G; Rosen G; Desbois JC
    Cancer; 1996 Nov; 78(10):2127-35. PubMed ID: 8918406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy in the treatment of osteosarcoma.
    Link MP
    Important Adv Oncol; 1986; ():193-207. PubMed ID: 3330533
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
    Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G
    J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
    Crews KR; Liu T; Rodriguez-Galindo C; Tan M; Meyer WH; Panetta JC; Link MP; Daw NC
    Cancer; 2004 Apr; 100(8):1724-33. PubMed ID: 15073863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative administration of high-dose methotrexate for osteosarcoma.
    Chan KW; Knowling MA; Duncan CP; Morton KS
    Can J Surg; 1984 May; 27(3):305-7, 309. PubMed ID: 6586272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy.
    Erttmann R; Bielack S; Landbeck G
    Cancer Chemother Pharmacol; 1985; 15(2):101-4. PubMed ID: 3874719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients.
    Tunn PU; Reichardt P
    Onkologie; 2007 May; 30(5):228-32. PubMed ID: 17460416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma.
    Abe K; Maeda-Minami A; Ishizu T; Iwata S; Kobayashi E; Shimoi T; Kawano Y; Hashimoto H; Yamaguchi M; Furukawa T; Miyazaki S; Mano Y
    Anticancer Res; 2022 Feb; 42(2):1043-1050. PubMed ID: 35093905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.
    Bacci G; Ferrari S; Delepine N; Bertoni F; Picci P; Mercuri M; Bacchini P; Brach del Prever A; Tienghi A; Comandone A; Campanacci M
    J Clin Oncol; 1998 Feb; 16(2):658-63. PubMed ID: 9469355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma.
    Bacci G; Loro L; Longhi A; Bertoni F; Bacchini P; Versari M; Picci P; Serra M
    Anticancer Drugs; 2006 Apr; 17(4):411-5. PubMed ID: 16549998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.